Report Highlights
Prostate Cancer Therapeutics Market – Scope of Report
TMR’s report on the global prostate cancer therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global prostate cancer therapeutics market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global prostate cancer therapeutics market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the prostate cancer therapeutics market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global prostate cancer therapeutics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global prostate cancer therapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global prostate cancer therapeutics market.
The report delves into the competitive landscape of the global prostate cancer therapeutics market. Key players operating in the global prostate cancer therapeutics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global prostate cancer therapeutics market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market prostate cancer therapeutics.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
- Company websites, presentations, annual reports, white papers, technical paper, product brochure
- Internal and external proprietary databases and relevant patents
- National government documents, statistical databases, and market reports
- News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
- Industry Sources:
- WorldWideScience.org
- Elsevier, Inc.
- National Institutes of Health (NIH)
- PubMed
- NCBI
- Department of Health Care Service
- Trade Data Sources
- Trade Map
- UN Comtrade
- Trade Atlas
- Company Information
- OneSource Business Browser
- Hoover’s
- Factiva
- Bloomberg
- Mergers & Acquisitions
- Thomson Mergers & Acquisitions
- MergerStat
- Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
- Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
- Helps in validating and strengthening secondary research findings
- Further develops the analysis team’s expertise and market understanding
- Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
- Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
- Purchasing/Sourcing managers, technical personnel, distributors
- Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
- Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
- Advanced Oncotherapy PLC
- Danfysik A/S
- Hitachi, Ltd.
- IBA Worldwide
- Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
- Table 1 : Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017–2031
- Table 2 : Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017–2031
- Table 3 : Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017–2031
- Table 4 : Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 5 : Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Region, 2017–2031
- Table 6 : North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017–2031
- Table 7 : North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017–2031
- Table 8 : North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017–2031
- Table 9 : North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 10 : North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country, 2017–2031
- Table 11 : Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017–2031
- Table 12 : Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017–2031
- Table 13 : Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017–2031
- Table 14 : Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 15 : Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 16 : Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017–2031
- Table 17 : Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017–2031
- Table 18 : Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017–2031
- Table 19 : Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 20 : Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 21 : Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017–2031
- Table 22 : Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017–2031
- Table 23 : Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017–2031
- Table 24 : Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 25 : Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 26 : Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017–2031
- Table 27 : Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017–2031
- Table 28 : Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy (Therapy), 2017–2031
- Table 29 : Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 30 : Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Figure 1 : Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, 2017–2032
- Figure 2 : Global Prostate Cancer Therapeutics Market Value Share, by Therapy, 2017 and 2031
- Figure 3 : Global Prostate Cancer Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hormone Therapy 2017–2031
- Figure 4 : Global Prostate Cancer Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemotherapy 2017–2031
- Figure 5 : Global Prostate Cancer Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Biologic Therapy 2017–2031
- Figure 6 : Global Prostate Cancer Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Targeted Therapy 2017–2031
- Figure 7 : Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2022–2031
- Figure 8 : Global Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2017 and 2031
- Figure 9 : Global Prostate Cancer Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies 2017–2031
- Figure 10 : Global Prostate Cancer Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2031
- Figure 11 : Global Prostate Cancer Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Sales, 2017–2031
- Figure 12 : Global Prostate Cancer Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031
- Figure 13 : Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022–2031
- Figure 14 : Global Prostate Cancer Therapeutics Market Value Share, by Region, 2017 and 2031
- Figure 15 : Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Region, 2022–2031
- Figure 16 : North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
- Figure 17 : North America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country, 2022–2031
- Figure 18 : North America Prostate Cancer Therapeutics Market Value Share, by Therapy, 2017 and 2031
- Figure 19 : North America Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2017 and 2031
- Figure 20 : North America Prostate Cancer Therapeutics Market Value Share, by Country, 2017 and 2031
- Figure 21 : North America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2022–2031
- Figure 22 : North America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022–2031
- Figure 23 : Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
- Figure 24 : Europe Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
- Figure 25 : Europe Prostate Cancer Therapeutics Market Value Share, by Therapy, 2017 and 2031
- Figure 26 : Europe Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2017 and 2031
- Figure 27 : Europe Prostate Cancer Therapeutics Market Value Share, by Country/Sub-region, 2017 and 2031
- Figure 28 : Europe Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 20122-2031
- Figure 29 : Europe Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022–2031
- Figure 30 : Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
- Figure 31 : Asia Pacific Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
- Figure 32 : Asia Pacific Prostate Cancer Therapeutics Market Value Share, by Therapy, 2017 and 2031
- Figure 33 : Asia Pacific Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2017 and 2031
- Figure 34 : Asia Pacific Prostate Cancer Therapeutics Market Value Share, by Country/Sub-region, 2017 and 2031
- Figure 35 : Asia Pacific Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2022–2031
- Figure 36 : Asia Pacific Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2017–2031
- Figure 37 : Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
- Figure 38 : Latin America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
- Figure 39 : Latin America Prostate Cancer Therapeutics Market Value Share, by Therapy, 2017 and 2031
- Figure 40 : Latin America Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2017 and 2031
- Figure 41 : Latin America Prostate Cancer Therapeutics Market Value Share, by Country/Sub-region, 2017 and 2031
- Figure 42 : Latin America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2022–2031
- Figure 43 : Latin America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022–2031
- Figure 44 : Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
- Figure 45 : Middle East & Africa Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
- Figure 46 : Middle East & Africa Prostate Cancer Therapeutics Market Value Share, by Therapy, 2017 and 2031
- Figure 47 : Middle East & Africa Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2017 and 2031
- Figure 48 : Middle East & Africa Prostate Cancer Therapeutics Market Value Share, by Country/Sub-region, 2017 and 2031
- Figure 49 : Middle East & Africa Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2022–2031
- Figure 50 : Middle East & Africa Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2017–2031
- Figure 51 : Global Prostate Cancer Therapeutics Market Share Analysis, by Company, 2021(Estimated)
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.
Similar Reports from Transparency
Prostate Cancer Therapeutics Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
Prostate Cancer Therapeutics Market - Scope of the Study
[206 Pages Report] Transparency Market Research (PMR) carried out a comprehensive analysis measuring the growth potential of the prostate cancer therapeutics market in its latest research report for the forecast period of 2019-2027. The business study encompasses some key insights for market players that can help them upkeep their position ...
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More